A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants

Clinical trial NCT02927067 · COMPLETED

Trial details

NCT number: NCT02927067
Sponsor: Shire
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cytomegalovirus (CMV)

Start date: 2017-04-14
Primary completion: 2022-07-01
Enrollment: 553

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.